BSPGHAN 2021 Virtual Annual Meeting

27- 29 April 2021

SETTING UP A REGIONAL HOME CALPROTECTIN SERVICE DURING THE COVID-19 PANDEMIC OFFERING HOSPITAL-BASED TESTING TO LOCAL AND REGIONAL PAEDIATRIC IBD PATIENTS IN WESSEX

Subscribe
Notify of
4 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
Eleni Volonaki
Eleni Volonaki
24 days ago

Well done for setting up an effective postal calprotectin service with a good uptake. In the Results, it became evident that you included both known IBD patients who had calprotectin measured as part of their monitoring, and suspected IBD patients, who had it as an initial screening test (rather than just known IBD patients, as mentioned in your Methods). I would have liked to see in a more clear way the impact of the availability of postal calprotectin on each of these populations.

Claire Barnes
Claire Barnes
20 days ago
Reply to  Eleni Volonaki

Thank you for your comments. The postal calprotectin had a significant impact on both of these populations. For those known to have IBD it was an ideal way of monitoring the disease, at a time when some families were reluctant to attend the hospital in view of COVID 19 and endoscopy services were limited. In 40% there was a change in management as a result of the faecal calprotectin. In addition we have had positive feedback from families about this service as a convenient, non-invasive way of monitoring IBD.

For those with suspected IBD and a normal faecal calprotectin, endoscopy could be avoided and the family reassured. For those with raised calprotectin, this highlighted the need for endoscopy, facilitated early identification of patients, even those who did not have much in terms of symptoms.

For both of these populations, having all the samples sent to the laboratory at the tertiary centre, facilitated easier access to results (rather that accessing from 12 regional hospitals) and meant they were all processed; some regional hospitals stopped providing this test during the COVID 19 pandemic.

Jutta Koeglmeier
Jutta Koeglmeier
19 days ago

congratulations on setting up a service for postal calprotectin during the COVID-19 pandemic. Can you please comment on other abnormal screening parameters used in addition to calprotectin

Claire Barnes
Claire Barnes
19 days ago

Thank you for your comments.
Bloods and endoscopy are other screening parameters used. During the COVID 19 pandemic access to endoscopy has been limited. Phlebotomy services have continue to run, but some families have understandably been reluctant to attend face to face. Postal faecal calprotectin has been ideal as patients can take the sample at home, send directly to the laboratory and be advised of results over the telephone.